BioCentury
ARTICLE | Clinical News

VA111913: Completed Phase I enrollment

March 30, 2009 7:00 AM UTC

Vantia completed enrollment of 99 healthy volunteers in a double-blind, placebo-controlled, single and multiple ascending-dose, U.K. Phase I trial evaluating oral VA111913. ...